This article provides a comprehensive overview of the current state of ex vivo expansion protocols for autologous cells, a critical process for cell therapies in immuno-oncology, autoimmunity, and hematopoietic transplantation.
This article provides researchers, scientists, and drug development professionals with a comprehensive guide to the specialized software platforms essential for modern cell therapy manufacturing.
This article provides a comprehensive analysis of cryopreservation methodologies critical for the success of autologous cell therapies.
This article provides a detailed examination of quality control (QC) testing for autologous cell products, a cornerstone for ensuring the safety and efficacy of these personalized advanced therapies.
This article provides a comprehensive overview of the current regulatory landscape for autologous cell therapies, tailored for researchers, scientists, and drug development professionals.
This article provides a detailed exploration of point-of-care (POC) devices for producing autologous cell concentrates, a transformative approach in decentralized therapy manufacturing.
This article provides a comprehensive analysis of closed automated systems for autologous cell manufacturing, a transformative approach addressing critical challenges in producing patient-specific therapies.
This article provides a comprehensive analysis of autologous cell products, a cornerstone of personalized medicine, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive resource for researchers and drug development professionals on the characterization of autologous mesenchymal stem cells (MSCs).
This article provides a comprehensive guide to Good Manufacturing Practice (GMP) for autologous cell therapies, tailored for researchers, scientists, and drug development professionals.